Related Experiment Video

Updated: Jun 29, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis

Ling-Zhi Liu1, Jenny Z Zheng, Xin-Ru Wang

  • 1Department of Pathology, Lab of Reproductive Medicine, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu, China.

Cancer Research
|October 3, 2008
PubMed

Insights

The p70 S6 kinase 1 (p70S6K1) in endothelial cells drives tumor growth and angiogenesis by regulating hypoxia-inducible factor-1alpha (HIF-1alpha). Inhibiting p70S6K1 reduces these effects, revealing a key signaling pathway in tumor development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Endothelial Cell Biology

Background:

  • p70 S6 kinase 1 (p70S6K1) is crucial for cellular processes like protein synthesis and proliferation.
  • The specific role of p70S6K1 in tumor growth and angiogenesis is not fully understood.
  • Endothelial cells play a vital role in tumor development and vascularization.

Purpose of the Study:

  • To investigate the effect of p70S6K1 in human dermal microvascular endothelial cells (HDMECs) on cancer-induced tumor growth and angiogenesis.
  • To elucidate the molecular mechanism by which p70S6K1 influences tumor angiogenesis.
  • To determine the role of the p70S6K1/hypoxia-inducible factor-1alpha (HIF-1alpha) signaling axis in endothelial cells during tumor development.

Main Methods:

  • Studied the impact of p70S6K1 activation and inhibition in HDMECs on tumor growth and angiogenesis.
  • Utilized constitutive activation and dominant-negative mutants of p70S6K1 in HDMECs.
  • Investigated the regulation of HIF-1alpha expression by p70S6K1 in endothelial cells and the effect of HIF-1alpha knockdown on tumor angiogenesis.

Main Results:

  • Constitutive activation of p70S6K1 in HDMECs significantly enhanced tumor growth and angiogenesis.
  • Inhibition of p70S6K1 in HDMECs impaired tumor growth and angiogenesis, indicating its necessity.
  • p70S6K1 was found to regulate HIF-1alpha expression in endothelial cells, and HIF-1alpha knockdown reduced tumor growth and angiogenesis.

Conclusions:

  • Endothelial p70S6K1 activity is essential for promoting tumor growth and angiogenesis.
  • The p70S6K1/HIF-1alpha signaling pathway in endothelial cells is a critical regulator of tumor angiogenesis.
  • This study provides insights into the molecular mechanisms underlying endothelial cell function in tumor microenvironment development and angiogenesis.

More Related Videos

Isolation and Culture Expansion of Tumor-specific Endothelial Cells10:15

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...